Rebeca Bailén-Almorox

10PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2025
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling.

Marina Gomez-Llobell, Carlos Serra Smith, Daniel Gómez-Costas

|Jun 24, 2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.

Maria Laura Fox, Irene García-Cadenas, Victor Navarro

|Feb 22, 2023
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.

Christelle Ferra Coll, Mireia Morgades de la Fe, Laura Prieto García

|Aug 20, 2022
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.

Pablo Silva de Tena, Rebeca Bailén, Gillen Oarbeascoa

|Jun 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

Ola Blennow, Jon Salmanton-García, Piotr Nowak

|Nov 03, 2020
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.

Rebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón

Pageof 2

Frequent Collaborators

2 joint publications

Cristina Pascual

2 joint publications

Diego Carbonell

2 joint publications

Mi Kwon

2 joint publications

Rodrigo Martino Bofarull